Trade Mark Journal No.2026/046 13 November 2026

WO0000001945300 (42)

Office of origin: United States of America

Date of International Registration:23 September 2026
Date of designation in the UK: 23 September 2026
Image for mark 1945300_TIF CRESCENT BIOPHARMA

International priority date claimed: 23 March 2026 (United States of America) (99718436)
Class 42
Pharmaceutical and biotechnological research and development in the fields of oncology, cancer, and radiology; pharmaceutical and biotechnological research and development.

Crescent Biopharma, Inc.

Representative: Christina M. Licursi, 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA